Skip to main content

Anixa Biosciences Inc

ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000715446

In the last 90 days, Anixa Biosciences Inc insiders filed 12 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.

Superinvestors holding ANIX, Q2 2026

See all superinvestors

No superinvestor reported holding ANIX in Q2 2026.